Horizon Therapeutics Public Limited Company announces an Equity Buyback for $500 million worth of its shares.

Horizon Therapeutics Public Limited Company (NasdaqGS:HZNP) announces a share repurchase program. Under the program, the company will repurchase up to $500 million worth of its shares. The company expects to fund the repurchase of its ordinary shares under the program with existing cash and cash equivalents.